Skip to main content
Premium Trial:

Request an Annual Quote

Deal with Affymetrix Enables CPGR to Expand Genomic Research Capabilities in Africa

NEW YORK (GenomeWeb News) – Affymetrix today announced a deal with the Centre for Proteomic and Genomic Research in South Africa to enable high-throughput genomics research and personalized medicine research across Africa.

Under the terms of the deal, CPGR will use Affy's GeneTitan Multi-Channel Instrument to provide gene expression and Axiom genotyping services to researchers in Africa. Further terms were not disclosed.

Genetic variation in African populations are "far greater" than in other regions in the world, Affy said, and in most studies of hereditary diseases and pharmacogenomics, African populations are underrepresented. Applying such genomic discoveries to clinical practices could improve the health of people across Africa, the Santa Clara, Calif.-based firm said.

"GeneTitan MC Instrument expands our genomics service capabilities and will further enable CPGR to support cutting-edge translational research in Africa," Reinhard Hiller, managing director of the center said in a statement. "We expect to progress to personalized medicine studies that aim to discover genetic markers specific in the African population for better diagnosis and drug treatment."

CPGR is a non-profit funded by the Technology Innovation Agency to provide services to the life science and biotechnology markets. It began offering genomic research services using Affy's GeneChip microarray platform in 2008.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.